Recently Diagnosed or Relapsed? Stop Looking For a Miracle Cure, and Use Evidence-Based Therapies To Enhance Your Treatment and Prolong Your Remission
Multiple Myeloma an incurable disease, but I have spent the last 25 years in remission using a blend of conventional oncology and evidence-based nutrition, supplementation, and lifestyle therapies from peer-reviewed studies that your oncologist probably hasn't told you about.
Click the orange button to the right to learn more about what you can start doing today.
- You are here:
- Home »
- Blog »
- Multiple Myeloma »
- When to Stop Myeloma Treatment?
When to Stop Myeloma Treatment?
When is it okay to stop myeloma treatment? Once a person is diagnosed with MM, they must grapple with the idea that their blood cancer is “treatable but incurable.” And anyone who has undergone aggressive MM therapy knows that chemo and radiation can make them feel awful.
The essay below designed a “structured interview” in an effort to determine how cancer patients and their caregivers felt about the challenging issue of when to stop myeloma treatment.
I’ve linked the short video below because it highlights several of the key issues in trying to understand treatment decisions for cancer patients.
When Should Dying Patients Stop Treatment?
While many MM therapies have a “curative intent” I’ve never heard of anyone being truly cured of MM. Though there are MM patients who achieve long-lasting remissions of 3-5 years or more, they are in the minority.
I guess my point, as a MM survivor myself who has undergone palliative care, is to learn about the risks and benefits of palliative care for MM patients. PC is not giving up. Pursuing quality of life does not mean the you are giving up on quantity of life.
Email me at David.PeopleBeatingCancer@gmail.com with questions you may have about palliative or hospice care and MM.
Good luck,
David Emerson
- MM Survivor
- MM Cancer Coach
- Director PeopleBeatingCancer
Fighting for Others: How Guilt and Obligation Drives the Desire for More Intensive Treatments in End-of-Life Cancer Care
Guilt and shame – not hope for recovery – are among the most common reasons terminally ill cancer patients continue with minimally beneficial treatments at the end of life, according to Rutgers researchers.
“In the United States, advanced illness care is enveloped in a set of moralized social attitudes around ‘fighting’ and ‘not giving up,’ where death is seen as the enemy, to be fought off at all costs,” said Login S. George, a health services researcher at the Rutgers Institute for Health, Health Care Policy and Aging Research, research member of the Cancer Prevention and Control Program at Rutgers Cancer Institute and lead author of the study published in the journal Health Psychology.
“This creates a dilemma for patients, who can feel like they are falling short of some moral code and disappointing others if they consider discontinuation of treatments,” George said. “Ours is among the first studies to quantify these sentiments.”
To assess end-of-life decision-making in terminally ill cancer patients, George and colleagues recruited 116 people receiving treatment at the Rutgers Cancer Institute, the state’s only NCI-designated Comprehensive Cancer Center, and other clinical sites between April 2022 and March 2024. Eligible participants had a median life expectancy of less than 12 months and were in the advanced stages of one of several cancers, including pancreatic, lung, colorectal or breast.
Participants answered structured interview questions, including those designed to assess whether guilt and a sense of duty pushed patients to continue nonbeneficial cancer treatments despite a poor prognosis.
Responses were analyzed to determine the association of such moral emotional processes with sociodemographic, distress and treatment decision-making variables.
In some questions, up to 88% of those interviewed said they continued potentially pointless treatments out of a moral obligation or for the benefit of loved ones. In response to the statement, “Stopping anticancer treatments would be a form of giving up on my family,”
- 19% of patients said, “a little,”
- 19% responded “somewhat,”
- 15.5% responded “quite a bit,”
- and 11.2% responded “a great deal.”
Similarly, up to 86% of patients reported they tried to appear more optimistic and physically well than they were feeling when loved ones were present. The instinct to downplay their discomfort even applied to how patients acted around their oncologists, with more than 41% saying they tried to appear more optimistic and healthier with doctors in the room, which in turn was associated with higher patient distress.
Previous studies have examined cancer patients’ feelings of guilt for burdening others with their care, but George said this study is novel because it focuses on an entirely different source of guilt – one stemming from “not abiding by the social code of battling cancer optimistically.”
“In an ideal world, a decision about stopping or continuing treatment would be guided by deliberation and intention and reflection on the part of patients, including open dialogue with others,” said George, who is also an assistant professor in the Rutgers School of Nursing. “But it appears that process can be restrained by some of these feelings of shame and obligation to others.”
George said the results have significant implications for end-of-life planning for those with advanced serious illness and should push families, loved ones and clinical providers to think deeply about what motivates patient preferences. That means helping patients recognize they have the choice, or permission, to discontinue treatments that are not seen to be worthwhile.
“Typically, doctors present people with information about treatment options and ask them what they want to do,” he said. “These results suggest we need to go a step further and discuss moral sentiments. Helping people articulate their feelings related to needing to continue treatments out of social expectations, or for the sake of others, could produce outcomes that are more in line with a patient’s actual wishes.”
stop myeloma treatment stop myeloma treatment stop myeloma treatment